AGÕæÈ˹ٷ½

STOCK TITAN

[8-K] Keurig Dr Pepper Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Keurig Dr Pepper Inc. (Nasdaq: KDP) used a Regulation FD presentation on 23â€�24 June 2025 to reaffirm its previously issued full-year 2025 outlook. Management reiterated two key non-GAAP targets:

  • Constant-currency net sales: expected to rise in the mid-single-digit percentage range versus 2024.
  • Adjusted diluted EPS: projected to expand in the high-single-digit percentage range.

No changes were made to the guidance originally communicated earlier in the year, signalling that current trading conditions and cost assumptions remain intact despite ongoing macroeconomic uncertainties. The filing contains standard cautionary language about forward-looking statements and highlights that reconciliations to GAAP metrics are not provided because mark-to-market and other uncontrollable items cannot be reasonably estimated.

The 8-K is furnished under Item 7.01 and therefore is not deemed "filed" for liability purposes under Section 18 of the Exchange Act. No other operational updates, financial tables, acquisitions, or management changes were disclosed.

Keurig Dr Pepper Inc. (Nasdaq: KDP) ha utilizzato una presentazione Regulation FD il 23â€�24 giugno 2025 per ribadire le previsioni per l'intero anno 2025 già comunicate in precedenza. La direzione ha confermato due obiettivi chiave non-GAAP:

  • Vendite nette a valuta costante: previste in aumento nella fascia delle percentuali a una cifra media rispetto al 2024.
  • EPS diluito rettificato: previsto in crescita nella fascia delle percentuali a una cifra alta.

Non sono state apportate modifiche alle indicazioni comunicate all'inizio dell'anno, segnalando che le condizioni di mercato attuali e le ipotesi sui costi rimangono invariate nonostante le incertezze macroeconomiche in corso. Il documento contiene il consueto linguaggio cautelativo sulle dichiarazioni previsionali e sottolinea che non sono fornite riconciliazioni con i parametri GAAP perché elementi come le valutazioni mark-to-market e altri fattori incontrollabili non possono essere ragionevolmente stimati.

L'8-K è presentato ai sensi dell'Item 7.01 e pertanto non è considerato "depositato" ai fini di responsabilità secondo la Sezione 18 dell'Exchange Act. Non sono stati divulgati altri aggiornamenti operativi, tabelle finanziarie, acquisizioni o cambiamenti nella direzione.

Keurig Dr Pepper Inc. (Nasdaq: KDP) utilizó una presentación bajo Regulation FD el 23â€�24 de junio 2025 para reafirmar sus perspectivas para todo el año 2025 previamente emitidas. La dirección reiteró dos objetivos clave no-GAAP:

  • Ventas netas a moneda constante: se espera que aumenten en un rango de porcentajes de un solo dígito medio respecto a 2024.
  • EPS diluido ajustado: se proyecta que crezca en un rango de porcentajes de un solo dígito alto.

No se realizaron cambios en la guía comunicada originalmente a principios de año, lo que indica que las condiciones actuales del mercado y las suposiciones de costos permanecen intactas a pesar de las incertidumbres macroeconómicas en curso. El documento incluye el lenguaje estándar de advertencia sobre declaraciones prospectivas y destaca que no se proporcionan conciliaciones con métricas GAAP porque los ajustes mark-to-market y otros elementos incontrolables no pueden estimarse razonablemente.

El formulario 8-K se presenta bajo el Item 7.01 y, por lo tanto, no se considera "presentado" para fines de responsabilidad según la Sección 18 de la Exchange Act. No se divulgaron otras actualizaciones operativas, tablas financieras, adquisiciones ni cambios en la dirección.

Keurig Dr Pepper Inc.(나스ë‹�: KDP)ëŠ� 2025ë…� 6ì›� 23~24ì� Regulation FD 프레젠테ì´ì…˜ì� 통해 ì´ì „ì—� 발표í•� 2025ë…� ì „ì²´ ì—°ë„ ì „ë§ì� 재확ì�했습니다. ê²½ì˜ì§„ì€ ë‘� 가지 주요 ë¹�-GAAP 목표ë¥� 재차 강조했습니다:

  • 환율 ì¡°ì • 순매ì¶�: 2024ë…� 대ë¹� 중간 í•� ìžë¦¿ìˆ� 비율ë¡� ì¦ê°€í•� 것으ë¡� 예ìƒë©ë‹ˆë‹�.
  • ì¡°ì • í¬ì„ 주당순ì´ì�(EPS): ë†’ì€ í•� ìžë¦¿ìˆ� 비율ë¡� 확대ë� ì „ë§ìž…니ë‹�.

ì—°ì´ˆì—� 발표í•� ê°€ì´ë˜ìФì—ëŠ� ë³€ê²� 사항ì� 없으ë©�, ì´ëŠ” 현재ì� 거래 환경ê³� 비용 ê°€ì •ì´ ì§€ì†ì ì� 거시경제 불확실성ì—ë„ ë¶ˆêµ¬í•˜ê³  변함없ìŒì„ ì˜ë¯¸í•©ë‹ˆë‹�. 제출 문서ì—는 미래 예측 진술ì—� 대í•� 표준 경고 문구가 í¬í•¨ë˜ì–´ 있으ë©�, 마í¬íˆ¬ë§ˆì¼� ë°� 기타 통제 불가능한 항목ì� 합리ì ìœ¼ë¡� 추정í•� ìˆ� 없기 때문ì—� GAAP 지표와ì� ì¡°ì • ë‚´ì—­ì€ ì œê³µë˜ì§€ 않는다고 명시ë˜ì–´ 있습니다.

8-K 보고서는 항목 7.01ì—� ë”°ë¼ ì œì¶œë˜ì—ˆìœ¼ë©°, ë”°ë¼ì„� ì¦ê¶Œê±°ëž˜ë²� 섹션 18ì—� 따른 ì±…ìž„ 목ì ìƒ� "제출ë�" 것으ë¡� 간주ë˜ì§€ 않습니다. 추가ì ì¸ ìš´ì˜ ì—…ë°ì´íЏ, 재무í‘�, ì¸ìˆ˜ ë˜ëŠ” ê²½ì˜ì§� ë³€ê²� ì‚¬í•­ì€ ê³µê°œë˜ì§€ 않았습니ë‹�.

Keurig Dr Pepper Inc. (Nasdaq : KDP) a utilisé une présentation Regulation FD les 23 et 24 juin 2025 pour °ùé²¹´Ú´Ú¾±°ù³¾±ð°ù ses prévisions pour l'ensemble de l'année 2025 précédemment communiquées. La direction a réitéré deux objectifs clés non-GAAP :

  • Ventes nettes à taux de change constants : prévues en hausse dans une fourchette de chiffres uniques moyens par rapport à 2024.
  • BPA dilué ajusté : projeté en croissance dans une fourchette de chiffres uniques élevés.

Aucune modification n’a été apportée aux prévisions initialement communiquées en début d’année, ce qui indique que les conditions commerciales actuelles et les hypothèses de coûts restent inchangées malgré les incertitudes macroéconomiques persistantes. Le document contient un langage standard d’avertissement concernant les déclarations prospectives et souligne que les rapprochements avec les normes GAAP ne sont pas fournis car les ajustements mark-to-market et autres éléments incontrôlables ne peuvent être raisonnablement estimés.

Le formulaire 8-K est déposé en vertu de l’Item 7.01 et n’est donc pas considéré comme "déposé" aux fins de responsabilité en vertu de la Section 18 du Exchange Act. Aucune autre mise à jour opérationnelle, tableau financier, acquisition ou changement de direction n’a été divulgué.

Keurig Dr Pepper Inc. (Nasdaq: KDP) nutzte am 23.â€�24. Juni 2025 eine Regulation FD-Präsentation, um seine zuvor veröffentlichten Prognosen für das Gesamtjahr 2025 zu bestätigen. Das Management bekräftigte zwei zentrale Non-GAAP-Ziele:

  • Umsatz in konstanter Währung: wird voraussichtlich im Bereich mittlerer einstelliger Prozentsätze gegenüber 2024 steigen.
  • Bereinigtes verwässertes Ergebnis je Aktie (EPS): wird voraussichtlich im Bereich hoher einstelliger Prozentsätze wachsen.

Es wurden keine Änderungen an der ursprünglich zu Jahresbeginn kommunizierten Prognose vorgenommen, was darauf hindeutet, dass die aktuellen Handelsbedingungen und Kostenannahmen trotz anhaltender makroökonomischer Unsicherheiten unverändert bleiben. Die Einreichung enthält die üblichen Warnhinweise zu zukunftsgerichteten Aussagen und weist darauf hin, dass keine Abstimmungen auf GAAP-Kennzahlen bereitgestellt werden, da Mark-to-Market- und andere nicht kontrollierbare Posten nicht vernünftig geschätzt werden können.

Das 8-K wurde gemäß Punkt 7.01 eingereicht und gilt daher für Haftungszwecke gemäß Abschnitt 18 des Exchange Act nicht als "eingereicht". Weitere operative Updates, Finanztabellen, Akquisitionen oder Managementänderungen wurden nicht bekannt gegeben.

Positive
  • Management reaffirmed mid-single-digit constant-currency net sales growth guidance.
  • Adjusted diluted EPS still expected to rise at a high-single-digit rate, indicating margin resilience and cost control.
  • Disclosure under Reg FD reduces information asymmetry for investors.
Negative
  • None.

Insights

TL;DR: Guidance unchanged; signals stability, modestly positive for sentiment.

The reiteration of mid-single-digit sales and high-single-digit EPS growth suggests management’s confidence in the 2025 plan despite inflationary and FX headwinds. Because investors were already modeling these figures, the news is unlikely to move estimates materially, but it does lower the probability of a near-term negative pre-announcement. Lack of GAAP reconciliation is standard for KDP. Overall impact is mildly positive: visibility is reaffirmed, but no upside revision was offered.

TL;DR: Neutral to slight positive—confirms thesis, no catalyst.

For portfolio positioning, the unchanged outlook keeps KDP within its typical low-volatility, cash-generative profile. The reaffirmation supports defensive allocations and dividend sustainability, yet absent upside revisions or new strategic initiatives, it is unlikely to trigger rerating. We view the disclosure as routine, with limited immediate impact on valuation multiples.

Keurig Dr Pepper Inc. (Nasdaq: KDP) ha utilizzato una presentazione Regulation FD il 23â€�24 giugno 2025 per ribadire le previsioni per l'intero anno 2025 già comunicate in precedenza. La direzione ha confermato due obiettivi chiave non-GAAP:

  • Vendite nette a valuta costante: previste in aumento nella fascia delle percentuali a una cifra media rispetto al 2024.
  • EPS diluito rettificato: previsto in crescita nella fascia delle percentuali a una cifra alta.

Non sono state apportate modifiche alle indicazioni comunicate all'inizio dell'anno, segnalando che le condizioni di mercato attuali e le ipotesi sui costi rimangono invariate nonostante le incertezze macroeconomiche in corso. Il documento contiene il consueto linguaggio cautelativo sulle dichiarazioni previsionali e sottolinea che non sono fornite riconciliazioni con i parametri GAAP perché elementi come le valutazioni mark-to-market e altri fattori incontrollabili non possono essere ragionevolmente stimati.

L'8-K è presentato ai sensi dell'Item 7.01 e pertanto non è considerato "depositato" ai fini di responsabilità secondo la Sezione 18 dell'Exchange Act. Non sono stati divulgati altri aggiornamenti operativi, tabelle finanziarie, acquisizioni o cambiamenti nella direzione.

Keurig Dr Pepper Inc. (Nasdaq: KDP) utilizó una presentación bajo Regulation FD el 23â€�24 de junio 2025 para reafirmar sus perspectivas para todo el año 2025 previamente emitidas. La dirección reiteró dos objetivos clave no-GAAP:

  • Ventas netas a moneda constante: se espera que aumenten en un rango de porcentajes de un solo dígito medio respecto a 2024.
  • EPS diluido ajustado: se proyecta que crezca en un rango de porcentajes de un solo dígito alto.

No se realizaron cambios en la guía comunicada originalmente a principios de año, lo que indica que las condiciones actuales del mercado y las suposiciones de costos permanecen intactas a pesar de las incertidumbres macroeconómicas en curso. El documento incluye el lenguaje estándar de advertencia sobre declaraciones prospectivas y destaca que no se proporcionan conciliaciones con métricas GAAP porque los ajustes mark-to-market y otros elementos incontrolables no pueden estimarse razonablemente.

El formulario 8-K se presenta bajo el Item 7.01 y, por lo tanto, no se considera "presentado" para fines de responsabilidad según la Sección 18 de la Exchange Act. No se divulgaron otras actualizaciones operativas, tablas financieras, adquisiciones ni cambios en la dirección.

Keurig Dr Pepper Inc.(나스ë‹�: KDP)ëŠ� 2025ë…� 6ì›� 23~24ì� Regulation FD 프레젠테ì´ì…˜ì� 통해 ì´ì „ì—� 발표í•� 2025ë…� ì „ì²´ ì—°ë„ ì „ë§ì� 재확ì�했습니다. ê²½ì˜ì§„ì€ ë‘� 가지 주요 ë¹�-GAAP 목표ë¥� 재차 강조했습니다:

  • 환율 ì¡°ì • 순매ì¶�: 2024ë…� 대ë¹� 중간 í•� ìžë¦¿ìˆ� 비율ë¡� ì¦ê°€í•� 것으ë¡� 예ìƒë©ë‹ˆë‹�.
  • ì¡°ì • í¬ì„ 주당순ì´ì�(EPS): ë†’ì€ í•� ìžë¦¿ìˆ� 비율ë¡� 확대ë� ì „ë§ìž…니ë‹�.

ì—°ì´ˆì—� 발표í•� ê°€ì´ë˜ìФì—ëŠ� ë³€ê²� 사항ì� 없으ë©�, ì´ëŠ” 현재ì� 거래 환경ê³� 비용 ê°€ì •ì´ ì§€ì†ì ì� 거시경제 불확실성ì—ë„ ë¶ˆêµ¬í•˜ê³  변함없ìŒì„ ì˜ë¯¸í•©ë‹ˆë‹�. 제출 문서ì—는 미래 예측 진술ì—� 대í•� 표준 경고 문구가 í¬í•¨ë˜ì–´ 있으ë©�, 마í¬íˆ¬ë§ˆì¼� ë°� 기타 통제 불가능한 항목ì� 합리ì ìœ¼ë¡� 추정í•� ìˆ� 없기 때문ì—� GAAP 지표와ì� ì¡°ì • ë‚´ì—­ì€ ì œê³µë˜ì§€ 않는다고 명시ë˜ì–´ 있습니다.

8-K 보고서는 항목 7.01ì—� ë”°ë¼ ì œì¶œë˜ì—ˆìœ¼ë©°, ë”°ë¼ì„� ì¦ê¶Œê±°ëž˜ë²� 섹션 18ì—� 따른 ì±…ìž„ 목ì ìƒ� "제출ë�" 것으ë¡� 간주ë˜ì§€ 않습니다. 추가ì ì¸ ìš´ì˜ ì—…ë°ì´íЏ, 재무í‘�, ì¸ìˆ˜ ë˜ëŠ” ê²½ì˜ì§� ë³€ê²� ì‚¬í•­ì€ ê³µê°œë˜ì§€ 않았습니ë‹�.

Keurig Dr Pepper Inc. (Nasdaq : KDP) a utilisé une présentation Regulation FD les 23 et 24 juin 2025 pour °ùé²¹´Ú´Ú¾±°ù³¾±ð°ù ses prévisions pour l'ensemble de l'année 2025 précédemment communiquées. La direction a réitéré deux objectifs clés non-GAAP :

  • Ventes nettes à taux de change constants : prévues en hausse dans une fourchette de chiffres uniques moyens par rapport à 2024.
  • BPA dilué ajusté : projeté en croissance dans une fourchette de chiffres uniques élevés.

Aucune modification n’a été apportée aux prévisions initialement communiquées en début d’année, ce qui indique que les conditions commerciales actuelles et les hypothèses de coûts restent inchangées malgré les incertitudes macroéconomiques persistantes. Le document contient un langage standard d’avertissement concernant les déclarations prospectives et souligne que les rapprochements avec les normes GAAP ne sont pas fournis car les ajustements mark-to-market et autres éléments incontrôlables ne peuvent être raisonnablement estimés.

Le formulaire 8-K est déposé en vertu de l’Item 7.01 et n’est donc pas considéré comme "déposé" aux fins de responsabilité en vertu de la Section 18 du Exchange Act. Aucune autre mise à jour opérationnelle, tableau financier, acquisition ou changement de direction n’a été divulgué.

Keurig Dr Pepper Inc. (Nasdaq: KDP) nutzte am 23.â€�24. Juni 2025 eine Regulation FD-Präsentation, um seine zuvor veröffentlichten Prognosen für das Gesamtjahr 2025 zu bestätigen. Das Management bekräftigte zwei zentrale Non-GAAP-Ziele:

  • Umsatz in konstanter Währung: wird voraussichtlich im Bereich mittlerer einstelliger Prozentsätze gegenüber 2024 steigen.
  • Bereinigtes verwässertes Ergebnis je Aktie (EPS): wird voraussichtlich im Bereich hoher einstelliger Prozentsätze wachsen.

Es wurden keine Änderungen an der ursprünglich zu Jahresbeginn kommunizierten Prognose vorgenommen, was darauf hindeutet, dass die aktuellen Handelsbedingungen und Kostenannahmen trotz anhaltender makroökonomischer Unsicherheiten unverändert bleiben. Die Einreichung enthält die üblichen Warnhinweise zu zukunftsgerichteten Aussagen und weist darauf hin, dass keine Abstimmungen auf GAAP-Kennzahlen bereitgestellt werden, da Mark-to-Market- und andere nicht kontrollierbare Posten nicht vernünftig geschätzt werden können.

Das 8-K wurde gemäß Punkt 7.01 eingereicht und gilt daher für Haftungszwecke gemäß Abschnitt 18 des Exchange Act nicht als "eingereicht". Weitere operative Updates, Finanztabellen, Akquisitionen oder Managementänderungen wurden nicht bekannt gegeben.

0001418135FALSE00014181352025-06-232025-06-23

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 23, 2025
KDP_LOGO_Full_Color.jpg
Keurig Dr Pepper Inc.
(Exact name of registrant as specified in its charter)
Delaware 001-33829 98-0517725
(State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)
53 South Avenue, Burlington, Massachusetts 01803
(Address of principal executive offices, including zip code)
781-418-7000
(Registrant’s telephone number including area code)
Not Applicable
(Former name or former address if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     Pre-commencement communications pursuant to Rule 13e-14(c) under the Exchange Act (17 CFR 240.13e-14(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Common stockKDP
Nasdaq Stock Market LLC



Item 7.01. Regulation FD Disclosure.
In connection with meetings with members of the investment community held on June 23–24, 2025, Keurig Dr Pepper Inc. (the “Company") is reaffirming its previously announced 2025 guidance for constant currency net sales growth in a mid-single-digit range and Adjusted diluted EPS growth in a high-single-digit range.
Non-GAAP Financial Measures
This Current Report on Form 8-K includes certain non-GAAP financial measures, including constant currency net sales and Adjusted diluted EPS, which differ from results using U.S. Generally Accepted Accounting Principles (GAAP). These non-GAAP financial measures should be considered as supplements to and should not be considered replacements for, or superior to, the GAAP measures. These measures may differ from similarly titled non-GAAP financial measures presented by other companies, and other companies may not define the non-GAAP financial measure in the same way. The most directly comparable GAAP financial measures for constant currency net sales and Adjusted diluted EPS are net sales and diluted EPS.
To the extent that the Company provides guidance, it does so only on a non-GAAP basis and does not provide reconciliations of such forward-looking non-GAAP measures to GAAP due to the inability to predict the amount and timing of impacts outside of the Company’s control on certain items, such as non-cash gains or losses resulting from mark-to-market adjustments of derivative instruments, among others, which could be material. Reconciling such items would require unreasonable efforts.
Forward-Looking Statements
This Current Report on Form 8-K contains “forward-looking statements” within the meaning of applicable securities laws and regulations. These forward-looking statements can generally be identified by the use of words such as “outlook,” “guidance,” “anticipate,” “expect,” “believe,” “could,” “estimate,” “feel,” “forecast,” “intend,” “may,” “plan,” “potential,” “project,” “should,” “target,” “will,” “would,” and similar words. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. These statements are based on the current expectations of our management, are not predictions of actual performance, and actual results may differ materially. Forward-looking statements are subject to a number of risks and uncertainties, including the factors disclosed in our Annual Report on Form 10-K and subsequent filings with the Securities and Exchange Commission. Our actual financial performance could differ materially from those projected in the forward-looking statements due to a variety of factors, including the inherent uncertainty of estimates, forecasts and projections, global economic uncertainty or economic downturns, tariffs or the imposition of new tariffs, trade wars, barriers or restrictions, or threats of such actions, and the possibility that we are unable to successfully integrate GHOST Lifestyle LLC (“GHOST”) into our business, and our financial performance may be better or worse than anticipated. We are under no obligation to update, modify or withdraw any forward-looking statements, except as required by applicable law.
The information presented in this Item 7.01 shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, unless the Company specifically states that the information is to be considered “filed” under the Exchange Act or specifically incorporates it by reference into a filing under the Securities Act of 1933, as amended, or the Exchange Act.




SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
     
 KEURIG DR PEPPER INC. 
Dated: June 23, 2025  
 By:  /s/ Anthony Shoemaker
  Name:  Anthony Shoemaker
  Title:  Chief Legal Officer, General Counsel and Secretary


FAQ

What 2025 sales growth guidance did Keurig Dr Pepper (KDP) reaffirm?

Mid-single-digit percentage growth in constant-currency net sales.

What is KDP’s outlook for 2025 adjusted diluted EPS?

Management continues to expect high-single-digit percentage growth versus 2024.

Does the 8-K include GAAP reconciliations for the non-GAAP figures?

No. The company states that predicting mark-to-market and other items would require unreasonable efforts.

Is this 8-K considered "filed" or "furnished"?

It is furnished under Item 7.01 and therefore not subject to Section 18 liability.

Were any acquisitions or leadership changes announced?

No. The filing solely reiterates 2025 financial guidance.
Keurig Dr Pepper Inc

NASDAQ:KDP

KDP Rankings

KDP Latest News

KDP Latest SEC Filings

KDP Stock Data

44.90B
1.29B
10.89%
81.3%
1.82%
Beverages - Non-Alcoholic
Beverages
United States
BURLINGTON